Brian Gloss
Brian Gloss
Westmead Research Hub
Verified email at
Cited by
Cited by
Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo
MC Milone, JD Fish, C Carpenito, RG Carroll, GK Binder, D Teachey, ...
Molecular therapy 17 (8), 1453-1464, 2009
lncRNAdb v2. 0: expanding the reference database for functional long noncoding RNAs
XC Quek, DW Thomson, JLV Maag, N Bartonicek, B Signal, MB Clark, ...
Nucleic acids research 43 (D1), D168-D173, 2015
The specificity of long noncoding RNA expression
BS Gloss, ME Dinger
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (1), 16-22, 2016
Unexpected features of the dark proteome
N Perdigão, J Heinrich, C Stolte, KS Sabir, MJ Buckley, B Tabor, B Signal, ...
Proceedings of the National Academy of Sciences 112 (52), 15898-15903, 2015
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells
KP Micklethwaite, K Gowrishankar, BS Gloss, Z Li, JA Street, L Moezzi, ...
Blood, The Journal of the American Society of Hematology 138 (16), 1391-1405, 2021
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
C Montavon, BS Gloss, K Warton, CA Barton, AL Statham, JP Scurry, ...
Gynecologic oncology 124 (3), 582-588, 2012
Realizing the significance of noncoding functionality in clinical genomics
BS Gloss, ME Dinger
Experimental & molecular medicine 50 (8), 1-8, 2018
Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells
DC Bishop, LE Clancy, R Simms, J Burgess, G Mathew, L Moezzi, ...
Blood, The Journal of the American Society of Hematology 138 (16), 1504-1509, 2021
Epigenetic biomarkers in epithelial ovarian cancer
BS Gloss, G Samimi
Cancer letters 342 (2), 257-263, 2014
Computational approaches for functional prediction and characterisation of long noncoding RNAs
B Signal, BS Gloss, ME Dinger
Trends in Genetics 32 (10), 620-637, 2016
Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage
JA Betts, MM Marjaneh, F Al-Ejeh, YC Lim, W Shi, H Sivakumaran, ...
The American Journal of Human Genetics 101 (2), 255-266, 2017
Methylation-capture and next-generation sequencing of free circulating DNA from human plasma
K Warton, V Lin, T Navin, NJ Armstrong, W Kaplan, K Ying, B Gloss, ...
BMC genomics 15, 1-13, 2014
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
PM O'Brien, MJ Davies, JP Scurry, AN Smith, CA Barton, MJ Henderson, ...
British journal of cancer 98 (6), 1085-1093, 2008
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
JA Byrne, S Maleki, JR Hardy, BS Gloss, R Murali, JP Scurry, S Fanayan, ...
BMC cancer 10, 1-11, 2010
Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers
BS Gloss, KI Patterson, CA Barton, M Gonzalez, JP Scurry, NF Hacker, ...
Cancer letters 318 (1), 76-85, 2012
Machine learning annotation of human branchpoints
B Signal, BS Gloss, ME Dinger, TR Mercer
Bioinformatics 34 (6), 920-927, 2018
Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype
F Valdes-Mora, R Salomon, BS Gloss, AMK Law, J Venhuizen, L Castillo, ...
Cell Reports 35 (2), 2021
Intergenic disease-associated regions are abundant in novel transcripts
N Bartonicek, MB Clark, XC Quek, JR Torpy, AL Pritchard, JLV Maag, ...
Genome biology 18, 1-16, 2017
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival
CA Barton, BS Gloss, W Qu, AL Statham, NF Hacker, RL Sutherland, ...
British journal of cancer 102 (1), 87-96, 2010
ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer
B Gloss, K Moran-Jones, V Lin, M Gonzalez, J Scurry, NF Hacker, ...
Molecular cancer 13, 1-10, 2014
The system can't perform the operation now. Try again later.
Articles 1–20